Candidate Markers of Olaparib Response from Genomic Data Analyses of Human Cancer Cell Lines

SIMPLE SUMMARY: Olaparib is an oral medication typically used to treat certain advanced ovarian and breast cancers with mutations in BRCA1 or BRCA2 genes. Mutations in these genes can increase the risk of developing breast, ovarian, and other types of cancer. Olaparib is the first clinically approve...

Descripción completa

Detalles Bibliográficos
Autores principales: Amuzu, Setor, Carmona, Euridice, Mes-Masson, Anne-Marie, Greenwood, Celia M. T., Tonin, Patricia N., Ragoussis, Jiannis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998846/
https://www.ncbi.nlm.nih.gov/pubmed/33803939
http://dx.doi.org/10.3390/cancers13061296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998846/
https://www.ncbi.nlm.nih.gov/pubmed/33803939
http://dx.doi.org/10.3390/cancers13061296

Ejemplares similares